G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells

Biochemical Pharmacology

Volumn 73, Issue 7, 2007, Pages 943-953

  Yoshida, Junko ^a   Ishibashi, Takaharu ^a   Nishio, Matomo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcium channel blocker; Cyclin dependent kinase; G1 cell cycle arrest; Human epidermoid carcinoma A431 cells; p21Waf1 Cip1; pRB

Indexed keywords

AMLODIPINE BESYLATE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLINE; DIHYDROPYRIDINE DERIVATIVE; DNA; NICARDIPINE; NIFEDIPINE; RETINOBLASTOMA PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

AMLODIPINE; CALCIUM CHANNEL BLOCKERS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYCLIN-DEPENDENT KINASES; DIHYDROPYRIDINES; G1 PHASE; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED;

EID: 33847105406     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.011     Document Type: Article

References (38)

1. Marche P., and Stepien O. Calcium antagonists and vascular smooth muscle cell reactivity. Z Kardiol 89 (2000) 140-144
2. 2+ stores in thrombin-stimulated vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 279 (2000) H1220-H1227
3. Stepien O., Zhang Y., Zhu D., and Marche P. Dual mechanism of action of amlodipine in human vascular smooth muscle cells. J Hypertens 20 (2002) 95-102
4. Zhang Y.Z., Gao P.J., Wang X.Y., Stepien O., Marche P., Zhang Z.L., et al. The inhibitory mechanisms of amlodipine in human vascular smooth muscle cell proliferation. Hypertens Res 23 (2000) 403-406
5. Taylor J.M., and Simpson R.U. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res 52 (1992) 2413-2418
6. Jensen R.L., Petr M., and Wurster R.D. Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation. Neurosurgery 46 (2000) 692-702
7. Jensen R.L., and Wurster R.D. Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol 55 (2001) 275-283
8. Jensen R.L., Origitano T.C., Lee Y.S., Weber M., and Wurster R.D. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36 (1995) 365-373
9. 2+ channel antagonists. Mol Chem Neuropathol 22 (1994) 81-95
10. + channel gating. Mol Pharmacol 59 (2001) 1376-1387
11. 2+ channel blockers on human epidermoid carcinoma A431 cells. Eur J Pharmacol 472 (2003) 23-31
12. 2+ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo. Eur J Pharmacol 492 (2004) 103-112
13. Moolenaar W.H., Aerts R.J., Tertoolen L.G., and de Laat S.W. The epidermal growth factor-induced calcium signal in A431 cells. J Biol Chem 261 (1986) 279-284
14. Gusev K., Glouchankova L., Zubov A., Kaznacheyeva E., Wang Z., Bezprozvanny I., et al. The store-operated calcium entry pathways in human carcinoma A431 cells: functional properties and activation mechanisms. J Gen Physiol 122 (2003) 81-94
15. CRAC-like calcium channels. Proc Natl Acad Sci USA 98 (2001) 148-153
16. 2+ channels. Science 287 (2000) 1647-1651
17. Parekh A.B., and Putney Jr. J.W. Store-operated calcium channels. Physiol Rev 85 (2005) 757-810
18. Pedersen S.F., Owsianik G., and Nilius B. TRP channels: an overview. Cell Calcium 38 (2005) 233-252
19. Vennekens R., Voets T., Bindels R.J., Droogmans G., and Nilius B. Current understanding of mammalian TRP homologues. Cell Calcium 31 (2002) 253-264
20. Clapham D.E. TRP channels as cellular sensors. Nature 426 (2003) 517-524
21. Montell C. The venerable inveterate invertebrate TRP channels. Cell Calcium 33 (2003) 409-417
22. 2+ signaling microdomains: platforms for the assembly and regulation of TRPC channels. Trends Pharmacol Sci 27 (2006) 25-32
23. 2+ entries and mRNA expression for TRPC1 and TRPC5 channels in human epidermoid carcinoma A431 cells. Eur J Pharmacol 510 (2005) 217-222
24. Kahl C.R., and Means A.R. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24 (2003) 719-736
25. 2+-ATPase. Proc Natl Acad Sci USA 87 (1990) 2466-2470
26. Yoshida J., Ishibashi T., and Nishio M. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor. Cancer Res 61 (2001) 6151-6157
27. Ekholm S.V., and Reed S.I. Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12 (2000) 676-684
28. Nevins J.R., Leone G., DeGregori J., and Jakoi L. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 173 (1997) 233-236
29. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
30. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 (1994) 59-66
31. Ewen M.E. Where the cell cycle and histones meet. Genes Dev 14 (2000) 2265-2270
32. Park D.J., Nakamura H., Chumakov A.M., Said J.W., Miller C.W., Chen D.L., et al. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene 9 (1994) 1899-1906
33. (Waf1/Cip1) gene activation. FASEB J 18 (2004) 1516-1523
34. Condorelli G., Aycock J.K., Frati G., and Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J 15 (2001) 2162-2170
35. KIP1 and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells. Arterioscler Thromb Vasc Biol 22 (2002) 1293-1298
36. 2+ signaling and control of growth and proliferation. Biol Cell 96 (2004) 55-68
37. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 90 (1993) 4986-4990
38. 2+-ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 276 (2001) 47608-47614